Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-13 5:02 pm Purchase | 2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT | Nan Fung Group Holdings Limited | 152,921 8.400% | 58,348 (+61.70%) | Filing History |
| 2021-04-07 4:30 pm Purchase | 2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT | RA Capital Management, L.P. | 118,916 6.500% | 118,916 (New Position) | Filing History |
| 2021-02-19 4:03 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 147,100 8.100% | 147,100 (New Position) | Filing History |
| 2021-02-18 4:50 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII, LLC | 113,650 6.600% | 113,650 (New Position) | Filing History |
| 2021-02-17 4:56 pm Purchase | 2021-02-09 | 13D | Bolt Biotherapeutics, Inc. BOLT | Nan Fung Group Holdings Limited | 94,573 5.500% | 94,573 (New Position) | Filing History |
| 2021-02-16 2:14 pm Purchase | 2021-02-04 | 13D | Bolt Biotherapeutics, Inc. BOLT | Sofinnova Venture Partners X L.P. | 137,722 8.000% | 137,722 (New Position) | Filing History |
| 2021-02-11 4:36 pm Purchase | 2021-02-04 | 13D | Bolt Biotherapeutics, Inc. BOLT | Novo Holdings A/S | 225,200 13.000% | 225,200 (New Position) | Filing History |